Annual Total Assets:
$95.28B-$4.55B(-4.56%)Summary
- As of today, TAK annual total assets is $95.28 billion, with the most recent change of -$4.55 billion (-4.56%) on March 31, 2025.
- During the last 3 years, TAK annual total assets has fallen by -$13.29 billion (-12.24%).
- TAK annual total assets is now -23.54% below its all-time high of $124.61 billion, reached on March 31, 2019.
Performance
TAK Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Assets:
$97.98B+$1.03B(+1.06%)Summary
- As of today, TAK quarterly total assets is $97.98 billion, with the most recent change of +$1.03 billion (+1.06%) on September 1, 2025.
- Over the past year, TAK quarterly total assets has dropped by -$3.90 billion (-3.83%).
- TAK quarterly total assets is now -22.10% below its all-time high of $125.77 billion, reached on June 30, 2019.
Performance
TAK Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
TAK Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -4.6% | -3.8% |
| 3Y3 Years | -12.2% | -2.8% |
| 5Y5 Years | -19.8% | -16.7% |
TAK Total Assets Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -12.2% | at low | -6.6% | +2.8% |
| 5Y | 5-Year | -19.8% | at low | -17.7% | +2.8% |
| All-Time | All-Time | -23.5% | +1296.9% | -22.1% | +361.3% |
TAK Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $97.98B(+1.1%) |
| Jun 2025 | - | $96.95B(+1.8%) |
| Mar 2025 | $95.28B(-4.6%) | $95.28B(-0.9%) |
| Dec 2024 | - | $96.12B(-5.7%) |
| Sep 2024 | - | $101.88B(+1.0%) |
| Jun 2024 | - | $100.88B(+1.1%) |
| Mar 2024 | $99.83B(-4.8%) | $99.83B(-1.0%) |
| Dec 2023 | - | $100.89B(+1.2%) |
| Sep 2023 | - | $99.66B(-2.6%) |
| Jun 2023 | - | $102.35B(-2.4%) |
| Mar 2023 | $104.87B(-3.4%) | $104.87B(+2.5%) |
| Dec 2022 | - | $102.35B(+1.5%) |
| Sep 2022 | - | $100.79B(-2.6%) |
| Jun 2022 | - | $103.53B(-4.6%) |
| Mar 2022 | $108.57B(-7.1%) | $108.57B(-1.5%) |
| Dec 2021 | - | $110.27B(-2.0%) |
| Sep 2021 | - | $112.57B(-1.3%) |
| Jun 2021 | - | $114.04B(-2.4%) |
| Mar 2021 | $116.85B(-1.6%) | $116.85B(-1.8%) |
| Dec 2020 | - | $119.00B(+1.2%) |
| Sep 2020 | - | $117.64B(+0.6%) |
| Jun 2020 | - | $116.92B(-1.6%) |
| Mar 2020 | $118.76B(-4.7%) | $118.76B(-1.0%) |
| Dec 2019 | - | $119.91B(+0.6%) |
| Sep 2019 | - | $119.18B(-5.2%) |
| Jun 2019 | - | $125.77B(+0.9%) |
| Mar 2019 | $124.61B(+222.7%) | $124.61B(+137.1%) |
| Dec 2018 | - | $52.57B(+39.7%) |
| Sep 2018 | - | $37.64B(+0.2%) |
| Jun 2018 | - | $37.55B(-2.7%) |
| Mar 2018 | $38.61B(-1.0%) | $38.61B(-1.4%) |
| Dec 2017 | - | $39.15B(+0.7%) |
| Sep 2017 | - | $38.87B(+0.5%) |
| Jun 2017 | - | $38.68B(-1.1%) |
| Mar 2017 | $39.01B(+14.7%) | $39.09B(+10.1%) |
| Dec 2016 | - | $35.51B(-5.4%) |
| Sep 2016 | - | $37.54B(+0.9%) |
| Jun 2016 | - | $37.21B(+9.4%) |
| Mar 2016 | $34.02B(-5.0%) | $34.02B(-2.3%) |
| Dec 2015 | - | $34.83B(-1.0%) |
| Sep 2015 | - | $35.18B(-0.4%) |
| Jun 2015 | - | $35.31B(-1.4%) |
| Mar 2015 | $35.82B(-19.3%) | $35.82B(-7.7%) |
| Dec 2014 | - | $38.81B(-6.9%) |
| Sep 2014 | - | $41.68B(-4.8%) |
| Jun 2014 | - | $43.80B(+3.1%) |
| Mar 2014 | $44.37B(+2.9%) | $42.48B(+0.9%) |
| Dec 2013 | - | $42.11B(-2.9%) |
| Sep 2013 | - | $43.34B(+9.5%) |
| Jun 2013 | - | $39.60B(-5.9%) |
| Mar 2013 | $43.10B | $42.07B(-3.9%) |
| Dec 2012 | - | $43.76B(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $44.76B(+3.0%) |
| Jun 2012 | - | $43.46B(-0.0%) |
| Mar 2012 | $43.47B(+29.3%) | $43.47B(-2.3%) |
| Dec 2011 | - | $44.47B(-2.0%) |
| Sep 2011 | - | $45.40B(+35.1%) |
| Jun 2011 | - | $33.60B(-0.1%) |
| Mar 2011 | $33.62B(+11.5%) | $33.62B(+1.7%) |
| Dec 2010 | - | $33.05B(+1.9%) |
| Sep 2010 | - | $32.42B(+6.9%) |
| Jun 2010 | - | $30.33B(+0.6%) |
| Mar 2010 | $30.14B(+8.3%) | $30.14B(+1.9%) |
| Dec 2009 | - | $29.58B(-3.4%) |
| Sep 2009 | - | $30.60B(+7.0%) |
| Jun 2009 | - | $28.61B(+2.8%) |
| Mar 2009 | $27.83B(-2.6%) | $27.83B(-1.2%) |
| Dec 2008 | - | $28.18B(+0.4%) |
| Sep 2008 | - | $28.06B(-0.1%) |
| Jun 2008 | - | $28.09B(-1.7%) |
| Mar 2008 | $28.58B(+10.5%) | - |
| Mar 2008 | - | $28.58B(+5.5%) |
| Dec 2007 | - | $27.10B(+3.1%) |
| Sep 2007 | - | $26.29B(+3.3%) |
| Jun 2007 | - | $25.45B(-1.6%) |
| Mar 2007 | $25.86B(+0.7%) | - |
| Mar 2007 | - | $25.86B(+3.4%) |
| Dec 2006 | - | $25.00B(+0.5%) |
| Sep 2006 | - | $24.87B(-4.0%) |
| Jun 2006 | - | $25.91B(+0.9%) |
| Mar 2006 | $25.68B(+7.9%) | - |
| Mar 2006 | - | $25.68B(+2.8%) |
| Dec 2005 | - | $24.98B(+0.3%) |
| Sep 2005 | - | $24.92B(+4.7%) |
| Jun 2005 | - | $23.79B(+0.5%) |
| Mar 2005 | $23.80B(+6.0%) | - |
| Mar 2005 | - | $23.68B(+11.5%) |
| Dec 2004 | - | $21.24B(-5.1%) |
| Sep 2004 | - | $22.38B(+2.4%) |
| Jun 2004 | - | $21.85B |
| Mar 2004 | $22.45B(+29.3%) | - |
| Mar 2003 | $17.37B(+17.1%) | - |
| Mar 2002 | $14.83B(+6.6%) | - |
| Mar 2001 | $13.91B(+2.0%) | - |
| Mar 2000 | $13.64B(+23.0%) | - |
| Mar 1999 | $11.09B(+18.3%) | - |
| Mar 1998 | $9.38B(-4.4%) | - |
| Mar 1997 | $9.81B(-6.8%) | - |
| Mar 1996 | $10.53B(-17.6%) | - |
| Mar 1995 | $12.77B(+25.2%) | - |
| Mar 1994 | $10.20B(+13.2%) | - |
| Mar 1993 | $9.01B(+22.5%) | - |
| Mar 1992 | $7.36B(+7.8%) | - |
| Mar 1991 | $6.82B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total assets?
- What is the all-time high annual total assets for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total assets year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total assets?
- What is the all-time high quarterly total assets for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total assets year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total assets?
The current annual total assets of TAK is $95.28B
What is the all-time high annual total assets for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total assets is $124.61B
What is Takeda Pharmaceutical Company Limited annual total assets year-on-year change?
Over the past year, TAK annual total assets has changed by -$4.55B (-4.56%)
What is Takeda Pharmaceutical Company Limited quarterly total assets?
The current quarterly total assets of TAK is $97.98B
What is the all-time high quarterly total assets for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total assets is $125.77B
What is Takeda Pharmaceutical Company Limited quarterly total assets year-on-year change?
Over the past year, TAK quarterly total assets has changed by -$3.90B (-3.83%)